Pfizer Inc. recalls Labetalol Hydrochloride Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility-The potential for incomplete crimp seals.
- Products
-
- Labetalol Hydrochloride Injection
- Company
- Pfizer Inc.
- Where it was sold
-
US Nationwide and Puerto Rico.
Nationwide
- Units affected
- 220,400 cartridges
- About this recall
- Labetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intravenous Injection Only, Rx Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-2339-24